The genome editing system CRISPR has become a hugely important tool in medical research, and could ultimately have a significant impact in fields such as agriculture, bioenergy, and food security.
The targeting system can travel to different points on the genome, guided by a short sequence of RNA, where a DNA-cutting enzyme known as Cas9 then makes the desired edits.
However, despite the gene-editing tool’s considerable success, CRISPR-Cas9 remains limited in the number of locations it can visit on the genome.
That is because CRISPR needs a specific sequence flanking the target location on the genome, known as a protospacer adjacent motif, or PAM, to allow it to recognize the site.
For example, the most widely used Cas9 enzyme, Streptococcus pyogenes Cas9 (SpCas9), requires two G nucleotides as its PAM sequence, significantly restricting the number of locations it can target, to around 9.9 percent of sites on the genome.
As yet, there are only a handful of CRISPR enzymes with minimal PAM requirements, meaning they are able to target a wider range of locations.
Now researchers at the MIT Media Lab and the Center for Bits and Atoms, led by Joseph Jacobson, a professor of media arts and sciences and head of the Molecular Machines research group, have discovered a Cas9 enzyme that can target almost half of the locations on the genome, significantly widening its potential use. They report their findings in Science Advances Oct. 24.
“CRISPR is like a very accurate and efficient postal system, that can reach anywhere you want to go very precisely, but only if the ZIP code ends in a zero,” Jacobson says. “So it is very accurate and specific, but it limits you greatly in the number of locations you can go to.”
To develop a more general CRISPR system, the researchers implemented computational algorithms to conduct a bioinformatics search of bacterial sequences, to determine if there were any similar enzymes with less restrictive PAM requirements.
To carry out the search, the researchers developed a data analysis software tool, which they called SPAMALOT (Search for PAMs by Alignment of Targets).
This revealed a number of interesting possible enzymes, but no clear winner. So the team then built synthetic versions of the CRISPRs in the laboratory, to evaluate their performance.
They found that the most successful enzyme, a Cas9 from Streptococcus canis (ScCas9), was strikingly similar to the Cas9 enzyme already widely used, according to co-lead author Pranam Chatterjee, a graduate student in the Media Lab, who carried out the research alongside fellow graduate student Noah Jakimo.
“The enzyme looks almost identical to the one that was originally discovered … but it is able to target DNA sequences that the commonly used enzyme cannot,” Chatterjee says.
Rather than two G nucleotides as its PAM sequence, the new enzyme needs just one G, opening up far more locations on the genome.
This should allow CRISPR to target many disease-specific mutations that have previously been out of reach of the system.
For example, a typical gene is around 1,000 bases in length, giving researchers a number of different locations to target if their aim is to simply knock out the entire gene, Jacobson says.
However, many diseases, such as sickle cell anemia, are caused by the mutation of a single base, making them much more difficult to target.
“Base editing is not just a matter of hitting that gene anywhere over the 1,000 bases and knocking it out; it is a matter of going in and correcting, in a very precise way, that one base that you want to change,” Jacobson says.
“You need to be able to go to that very exact location, put your piece of CRISPR machinery right next to it, and then with a base editor — another protein that’s attached to the CRISPR — go in and repair or change the base,” he says.
The new CRISPR tool could be particularly helpful in such applications.
“We are excited to get ScCas9 into the hands of the genome editing community and receive their feedback for future development,” Chatterjee says.
The researchers very elegantly took advantage of the natural evolution of Cas9 sequences in Streptococcus bacteria in order to identify the new Cas9 protein, which will be a powerful tool for genome editing, says Jean-Paul Concordet, a CRISPR specialist at the National Museum of Natural History in France, who was not involved in the research.
“The amino acid sequence of ScCas9 is very closely related to that of SpCas9, so the anticipation is that it will also prove very easy to produce in recombinant form and can directly benefit from all the developments made for SpCas9,” Concordet says.
“In addition, ScCas9 works with the same guide RNAs as SpCas9, so it will be possible to use synthetic guide RNAs that are readily available from different companies,” he says.
The researchers are now hoping to use their technique to find other enzymes that could expand the targeting range of the CRISPR system even further, without reducing its accuracy, according to Jacobson.
“We feel confident of being able to go after every address on the genome,” he says.
The Latest on: CRISPR
via Google News
The Latest on: CRISPR
- A Hands-On Look At Gene-Editing Technique CRISPR, Which Could Be A Game-Changer For Ag on December 16, 2018 at 8:29 pm
In a lab at George Washington University, painted lady butterflies flutter in mesh houses. This is where assistant professor Arnault Martin and his research group use the new gene-editing technique CR... […]
- Crispr Babies, IVF, and the Ethics of Genetic Class Warfare on December 16, 2018 at 10:22 am
Last month, Chinese national He Jiankui flouted a vigorous scientific debate when he told a room full of scientists that he had manipulated the embryos of Chinese twins, using Crispr to make one resis... […]
- CRISPR Without the Chop Reverses Genetic Obesity in Mice on December 14, 2018 at 6:38 am
Scientists at the University of California San Francisco (UCSF) have used a modified version of CRISPR technology to reverse genetic forms of severe obesity in two different mouse models, but without ... […]
- Follow These Simple Rules For Precise CRISPR Gene Editing on December 14, 2018 at 6:29 am
CRISPR/Cas9 gene editing in human cells is not an exact science—yet. Most cases of its use so far are fairly experimental; scientists can’t always predict precisely how DNA will be modified. Maybe the... […]
- CRISPR gene therapy regulates hunger, staves off severe obesity in mice on December 14, 2018 at 3:42 am
CRISPR gene editing technologies offer some exciting possibilities for medicine, whether it’s helping to treat ALS, battling the spread of malaria, or potentially providing us with a limitless supply ... […]
- CRISPR joins battle of the bulge, fights obesity without edits to genome on December 13, 2018 at 11:04 am
A weighty new study shows that CRISPR therapies can cut fat without cutting DNA. In a paper published Dec. 13, 2018, in the journal Science, UC San Francisco researchers describe how a modified ... […]
- CRISPR controls obesity in mice by amplifying rather than editing genes on December 13, 2018 at 10:13 am
The genes SIM1 and MC4R regulate food intake by signaling the feeling of being full, which is why mutations in those genes are associated with severe obesity. Even if just one of the two copies of tho... […]
- Scientists crack the CRISPR code for precise human genome editing on December 13, 2018 at 8:05 am
Illustration of the CRISPR/Cas9 genome editing system. Credit: Nigel Hawtin for the Francis Crick Institute Scientists at the Francis Crick Institute have discovered a set of simple rules that ... […]
- China's Gene-Editing Scientists Still Aiming for Crispr Supremacy on December 12, 2018 at 8:00 am
Chinese scientists are pressing ahead with their attempts to perfect human gene-editing technology, even after one of their compatriots drew a global backlash for editing the genes of twin girls. In r... […]
via Bing News